Please Wait.....
Report
GCC Generic Injectables Market Report by Container Type (Vials, Prefilled Syringes, Ampoules, Premix, and Others), Therapeutic Area (Oncology, Anaesthesia, Anti-infectives, Cardiovascular, Parenteral Nutrition, and Others), Distribution Channel (Hospitals, Clinics, Retail Pharmacy Stores), and Region 2024-2032
Market Report I 2024-03-02 I 135 Pages I IMARC Group
The GCC generic injectables market size reached US$ 685.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,814.4 Million by 2032, exhibiting a growth rate (CAGR) of 11.1% during 2024-2032. The growing investment by pharmaceutical companies in marketing innovative drugs, less approval time, and domestic manufacturing in the GCC region represent some of the key factors driving the market.
Rising Prevalence of Chronic Diseases Impelling Market Growth
The growing population and rising occurrence of chronic diseases and non-communicable diseases (NCDs) currently represent one of the primary factors driving the sales of generic injectables in the GCC region. With the growing geriatric population in the region, the deaths and disabilities caused due to NCDs are rising. High-valued patented injectables add more cost, whereas generic injectables do the same job at a lower price, thereby making them affordable to maximum patients.
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is fragmented with a number of global and regional players operating in the industry. The volume of new entrants is moderate in the GCC generic injectables industry as the high market growth and low product differentiation and switching costs, attract new entrants to enter the market. However, high capital investment prevents new entrants from foraying into the industry.
What are Generic Injectables?
Generic injectables are pharmaceutical drugs which are equivalent to brand-name injectables with respect to dosage, strength, route of administration, quality, performance, and intended use. These injectables are made available in the market after the patent expiration of branded injectables. They undergo complex manufacturing processes, but cheaper and shorter research and development (R&D) cycles as compared to branded injectables. Generic injectables are less expensive than branded injectables and, thereby contribute to significant savings for patients and healthcare providers. They are widely used in the treatment of various chronic diseases, such as cancer, diabetes, cardiovascular diseases, respiratory diseases, rheumatoid arthritis, osteoarthritis, and osteoporosis.
COVID-19 Impact:
The rapid spread of COVID-19 in the GCC countries has adversely impacted various businesses across the region. In order to slow down the spread, governing agencies in the region have taken various measures, including the closing of borders, suspension of air traffic, and imposition of a comprehensive quarantine. The rapid spread of the virus has negatively impacted both the supply and demand across the region. Supply chain disruptions, reduced availability of raw materials, factory shutdowns, and trade bans are some of the major factors that have impacted the supply. The outbreak of COVID-19 has also impacted supply chains in the GCC pharmaceutical industry. This was true not only for finished products but also for raw materials. The countries in the GCC region were facing interruptions in the supply of generic drugs as the majority of the generic drug demand in the region were fulfilled by imports. Logistics services were the primary reason for this disruption. As a consequence of this, countries in the region, especially Saudi Arabia and UAE, were fostering the localization and encouraging local production of generic drugs to reduce the impact of any disruptions. This, in turn, is expected to provide a positive impetus to the GCC generic injectables sector.
GCC Generic Injectables Market Trends:
At present, the rising demand for generic injectables on account of the high affordability, as they do not require extensive research and testing and saves both money and time, represents one of the key factors supporting the growth of the market in the GCC region. Besides this, generic injectables require lower capital investment compared to patented injectables, as key manufacturers do not invest in drug discovery and various clinical trials since it is previously verified for the patented injectable, which is impelling the growth of the market in the region. In addition, the growing demand for generic injectables due to less approval time is offering a favorable market outlook in the GCC region. Moreover, the increasing investment by pharmaceutical companies in marketing innovative drugs, as they need to educate both physicians and authorities on the efficacy and safety profile of new drugs, is strengthening the growth of the market. Apart from this, governing agencies in the GCC region are encouraging domestic manufacturing of generic injectables, which is offering lucrative growth opportunities to industry investors. Additionally, the growing prevalence of acute and chronic disease cases due to the rising emigrant population in the region is positively influencing the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the GCC generic injectables market report, along with forecasts at the regional and country level from 2024-2032. Our report has categorized the market based on container type, therapeutic area and distribution channel.
Container Type Insights:
Vials
Prefilled Syringes
Ampoules
Premix
Others
The report has provided a detailed breakup and analysis of the GCC generic injectables market based on the container type. This includes vials, prefilled syringes, ampoules, premix, and others. According to the report, vials represented the largest segment, as they are small glasses or plastic vessels, often used to store medication in several forms, such as liquids, powders, or capsules. In addition, the growing demand for vials due to the lower risk of breakage and contamination is offering a favorable market outlook.
Therapeutic Area Insights:
Oncology
Anaesthesia
Anti-infectives
Cardiovascular
Parenteral Nutrition
Others
A detailed breakup and analysis of the GCC generic injectables market based on the therapeutic area has also been provided in the report. This includes oncology, anaesthesia, anti-infectives, cardiovascular, parenteral nutrition, and others. According to the report, oncology accounted for the largest market share due to the rising prevalence of cancer in the region. Moreover, various government and non-government organizations are promoting the manufacturing of generic oncology injectables to provide treatment to the maximum number of people at affordable rates.
Distribution Channel Insights:
Hospitals
Clinics
Retail Pharmacy Stores
A detailed breakup and analysis of the GCC generic injectables market based on the distribution channel has also been provided in the report. This includes hospitals, clinics, and retail pharmacy stores. According to the report, hospitals accounted for the largest market share, as injectables cannot be traded without prescription from a certified practitioner due to stringent regulations in the GCC countries. Moreover, the rapid increase in non-communicable diseases (NCDs) has prompted investments in specialized hospitals and clinics with advanced technologies and improved capabilities.
Regional Insights:
Saudi Arabia
UAE
Kuwait
Qatar
Oman
Bahrain
The report has also provided a comprehensive analysis of all the major regional markets, which include Saudi Arabia, UAE, Kuwait, Qatar, Oman, and Bahrain. According to the report, Saudi Arabia was the largest market for GCC generic injectables. Some of the factors driving the Saudi Arabia generic injectables market included the growing domestic generic injectable manufacturing base, rising prevalence of chronic diseases, and new product launches. In addition, the increasing healthcare expenditure, along with favorable government initiatives, is offering lucrative growth opportunities to industry investors. Moreover, the transition of public hospitals to an increasingly privatized and comprehensive healthcare system in Saudi Arabia is catalyzing the demand for generic injectables.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the GCC generic injectables market.
Key Questions Answered in This Report
1. What was the size of the GCC generic injectables market in 2023?
2. What is the expected growth rate of the GCC generic injectables market during 2024-2032?
3. What are the key factors driving the GCC generic injectables market?
4. What has been the impact of COVID-19 on the GCC generic injectables market?
5. What is the breakup of the GCC generic injectables market based on the container type?
6. What is the breakup of the GCC generic injectables market based on the therapeutic area?
7. What is the breakup of the GCC generic injectables market based on the distribution channel?
8. What are the key regions in the GCC generic injectables market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 GCC Generic Injectables Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Region
5.5 Market Breakup by Therapeutic Area
5.6 Market Breakup by Container Type
5.7 Market Breakup by Distribution Channel
5.8 Market Forecast
5.9 SWOT Analysis
5.9.1 Overview
5.9.2 Strengths
5.9.3 Weaknesses
5.9.4 Opportunities
5.9.5 Threats
5.10 Value Chain Analysis
5.10.1 Research and Development
5.10.2 Manufacturing
5.10.3 Marketing and Distribution
5.11 Porter's Five Forces Analysis
5.11.1 Overview
5.11.2 Bargaining Power of Supplier
5.11.3 Bargaining Power of Buyers
5.11.4 Degree of Competition
5.11.5 Threat of New Entrants
5.11.6 Threat of Substitutes
5.12 Price Analysis
5.12.1 Key Price Indicators
5.12.2 Price Structure
5.12.3 Margin Analysis
5.13 Key Market Drivers and Success Factors
6 Market Performance by Key Regions
6.1 Saudi Arabia
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 UAE
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Kuwait
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Qatar
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Oman
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Bahrain
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Performance by Container Type
7.1 Vials
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Prefilled Syringes
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Ampoules
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Premix
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Performance by Therapeutic Area
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Anaesthesia
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Anti-infectives
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cardiovascular
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Parenteral Nutrition
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Performance by Distribution Channel
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Retail Pharmacy Stores
9.3.1 Market Trends
9.3.2 Market Forecast
10 Competitive Landscape
10.1 Market Structure
10.2 Key Players
11 Generic Injectable Manufacturing Process
11.1 Product Overview
11.2 Detailed Process Flow
11.3 Various Types of Unit Operations Involved
11.4 Mass Balance and Raw Material Requirements
12 Project Details, Requirements and Costs Involved
12.1 Land, Location and Site Development
12.2 Construction Requirements
12.3 Machinery Requirements
12.4 Machinery Pictures
12.5 Raw Material Requirements
12.6 Raw Material and Final Product Pictures
12.7 Packaging Requirements
12.8 Transportation Requirements
12.9 Utility Requirements
12.10 Manpower Requirements
12.11 Other Capital Investments
13 Key Player Profiles
Figure 1: GCC: Generic Injectables Market: Major Drivers and Challenges
Figure 2: GCC: Generic Injectables Market: Sales Value (in Million US$), 2018-2023
Figure 3: GCC: Generic Injectables Market: Breakup by Region (in %), 2023
Figure 4: GCC: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2023
Figure 5: GCC: Generic Injectables Market: Breakup by Container Type (in %), 2023
Figure 6: GCC: Generic Injectables Market: Breakup by Distribution Channel (in %), 2023
Figure 7: GCC: Generic Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 8: GCC: Generic Injectables Industry: SWOT Analysis
Figure 9: GCC: Generic Injectables Industry: Value Chain Analysis
Figure 10: GCC: Generic Injectables Industry: Porter's Five Forces Analysis
Figure 11: Saudi Arabia: Generic Injectables Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Saudi Arabia: Generic Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: UAE: Generic Injectables Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: UAE: Generic Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Kuwait: Generic Injectables Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Kuwait: Generic Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Qatar: Generic Injectables Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Qatar: Generic Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Oman: Generic Injectables Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Oman: Generic Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Bahrain: Generic Injectables Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Bahrain: Generic Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: GCC: Generic Injectables (in Vials) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: GCC: Generic Injectables (in Vials) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: GCC: Generic Injectables (in Prefilled Syringes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: GCC: Generic Injectables (in Prefilled Syringes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: GCC: Generic Injectables (in Ampoules) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: GCC: Generic Injectables (in Ampoules) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: GCC: Generic Injectables (in Premix) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: GCC: Generic Injectables (in Premix) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: GCC: Generic Injectables (in Other Container Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: GCC: Generic Injectables (in Other Container Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: GCC: Generic Injectables (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: GCC: Generic Injectables (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: GCC: Generic Injectables (Anaesthesia) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: GCC: Generic Injectables (Anaesthesia) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: GCC: Generic Injectables (Anti-infectives) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: GCC: Generic Injectables (Anti-infectives) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: GCC: Generic Injectables (Cardiovascular) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: GCC: Generic Injectables (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: GCC: Generic Injectables (Parenteral Nutrition) Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: GCC: Generic Injectables (Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: GCC: Other Generic Injectables Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: GCC: Other Generic Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: GCC: Generic Injectables Market: Sales through Hospitals (in Million US$), 2018 & 2023
Figure 46: GCC: Generic Injectables Market Forecast: Sales through Hospitals (in Million US$), 2024-2032
Figure 47: GCC: Generic Injectables Market: Sales through Clinics (in Million US$), 2018 & 2023
Figure 48: GCC: Generic Injectables Market Forecast: Sales through Clinics (in Million US$), 2024-2032
Figure 49: GCC: Generic Injectables Market: Sales through Retail Pharmacy Stores (in Million US$), 2018 & 2023
Figure 50: GCC: Generic Injectables Market Forecast: Sales through Retail Pharmacy Stores (in Million US$), 2024-2032
Figure 51: Generic Injectables Manufacturing: Detailed Process Flow
Figure 52: Generic Injectables Manufacturing Process: Conversion Rate of Feedstocks
Figure 53: Generic Oncology Drug Manufacturing Plant: Tertiary Packaging
Figure 54: Generic Injectables Manufacturing Process: Breakup of Capital Costs (in %)
Figure 55: Generic Injectables Industry: Breakup of Profit Margins at Various Level of the Value Chain
Table 1: GCC: Generic Injectables Market: Key Industry Highlights, 2023 and 2032
Table 2: GCC: Generic Injectables Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 3: GCC: Generic Injectables Market Forecast: Breakup by Container Type (in Million US$), 2024-2032
Table 4: GCC: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2024-2032
Table 5: GCC: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: GCC: Generic Injectables Industry: Competitive Structure
Table 7: GCC: Generic Injectables Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security